Abstract
Hydrogels have emerged as an unique and potential transporters for the target drug delivery systems in cancer therapy. Cancer is a terrible disease extracting toll on human health across the world probably due to several drawbacks of the conventional cancer treatments. However, hydrogels facilitate the modern and improved prospects for the treatment of cancer with minimum cytotoxic effects to the healthier cells or tissues. Besides, the easy tailoring associated with the structural features and high biocompatibility of hydrogels have attracted enough attention and offer them as a strong tool for the development of nanomedicine. This review is devoted to update the current studies related to hydrogels and their applications as vectors for cancer chemotherapy.
Keywords: Biocompatibility, cancer chemotherapy, drug delivery, hydrogels, nanomedicine.
Current Cancer Therapy Reviews
Title:Potentials of Hydrogels in Cancer Therapy
Volume: 10 Issue: 3
Author(s): Prem Prakash Sharma, Ravindra Kumar, Anil K Singh, Brajendra K Singh, Ajay Kumar and Brijesh Rathi
Affiliation:
Keywords: Biocompatibility, cancer chemotherapy, drug delivery, hydrogels, nanomedicine.
Abstract: Hydrogels have emerged as an unique and potential transporters for the target drug delivery systems in cancer therapy. Cancer is a terrible disease extracting toll on human health across the world probably due to several drawbacks of the conventional cancer treatments. However, hydrogels facilitate the modern and improved prospects for the treatment of cancer with minimum cytotoxic effects to the healthier cells or tissues. Besides, the easy tailoring associated with the structural features and high biocompatibility of hydrogels have attracted enough attention and offer them as a strong tool for the development of nanomedicine. This review is devoted to update the current studies related to hydrogels and their applications as vectors for cancer chemotherapy.
Export Options
About this article
Cite this article as:
Prakash Sharma Prem, Kumar Ravindra, K Singh Anil, K Singh Brajendra, Kumar Ajay and Rathi Brijesh, Potentials of Hydrogels in Cancer Therapy, Current Cancer Therapy Reviews 2014; 10 (3) . https://dx.doi.org/10.2174/157339471003150212111617
DOI https://dx.doi.org/10.2174/157339471003150212111617 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Graphene and Graphene Oxide as a Docking Station for Modern Drug Delivery System
Current Drug Delivery Targeted Delivery of Anti-Inflammatory Agents to Tumors
Current Pharmaceutical Design Small Molecules Targeting Mutant P53: A Promising Approach for Cancer Treatment
Current Medicinal Chemistry Transposable Elements in Cancer and Other Human Diseases
Current Cancer Drug Targets Medical Applications of Implantable Drug Delivery Microdevices Based on MEMS (Micro-Electro-Mechanical-Systems)
Current Pharmaceutical Biotechnology Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging
Current Medicinal Chemistry Prognostic Role of Hedgehog-GLI1 Signaling Pathway in Aggressive and Metastatic Breast Cancers
Current Drug Metabolism DNA-Based Methods to Prepare Helper Virus-Free Herpes Amplicon Vectors and Versatile Design of Amplicon Vector Plasmids
Current Gene Therapy Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription Factor
Current Pharmaceutical Design Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets Approaches to Improve Efficiency of Dendritic Cell-based Therapy of High Grade Gliomas
Current Pharmaceutical Design Editorial (Hot Topic: Translational Medicine is Promoting Cross-talk of Interdiscipline)
Anti-Cancer Agents in Medicinal Chemistry Light Chain LC and TAT-EGFP-HCS of Botulinum Toxin Expression and Biological Function <i>in vitro</i> and <i>in vivo</i>
Current Proteomics Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy
Current Cancer Drug Targets Targeting the Mevalonate Pathway for Improved Anticancer Therapy
Current Cancer Drug Targets The Dark Side of Stem Cells: Triggering Cancer Progression by Cell Fusion
Current Molecular Medicine Nucleic Acid Carrier Systems Based on Polyethylenimine Conjugates for the Treatment of Metastatic Tumors
Current Medicinal Chemistry Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Current Medicinal Chemistry - Anti-Cancer Agents